Although mutations in MTOR itself, previously reported in chRCC, were not detected, we observed frequent alterations in PTEN (n = 29, 16.1%) and TSC2 (n = 7, 3.9%) [17,20,21]. This evidence concerns the gene TSC2 and chromophobe renal cell carcinoma.